Figure 1.

a: Means (± standard deviation) of plasma concentrations of zoledronic acid after 1st infusion in Arm1 (n = 11) patients who received zoledronic acid, thalidomide and prednisolone. b: Means (± standard deviation) of plasma concentrations of zoledronic acid after 1st infusion in Arm2 (n = 12) patients who received zoledronic acid alone.

Spencer et al. BMC Clinical Pharmacology 2008 8:2   doi:10.1186/1472-6904-8-2
Download authors' original image